Acadia Healthcare Q4 revenue up 13.8% to $675.3M; guides FY2023 adj. EPS $3.10-3.40

Acadia Healthcare Company, Inc.

2022-FY EPS reported $2.98 revenue$2,610,399,000

Q4 net income $61.1M ($0.67 diluted EPS); adjusted EPS $0.74, including $0.04 from CARES Act PRF.
Same facility revenue +9.4% YoY on 5.2% revenue per patient day and 4.0% patient day growth.
FY2023 guidance: revenue $2.82-2.88B, adj. EBITDA $635-675M, adj. EPS $3.10-3.40.
Q1 2023 guidance: revenue $690-700M, adj. EBITDA $145-150M, adj. EPS $0.70-0.74.
Added 80 beds in Q4; opened joint venture facility in Ft. Wayne and acquired four CTCs in Georgia.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Acadia Healthcare Company, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $675.3 million, net income $61.1 million, EPS $0.67 per diluted share. Guidance initiated.

Period: the fourth quarter ended December 31, 2022
Revenue: $675.3 million
Net income: $61.1 million
EPS: $0.67 per diluted share
Guidance: initiated
Result: reported results

Exact text from the filing

Revenue totaled $675.3 million, an increase of 13.8% over the fourth quarter of 2021 Same facility revenue increased 9.4% compared to the fourth quarter of 2021, including an increase in revenue per patient day of 5.2% and an increase in patient days of 4.0% Net income attributable to Acadia totaled $61.1 million, or $0.67 per diluted share

View on SEC.gov

Browse all earnings releases →

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-23-000366

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.